These C. elegans results are similar to those observed in the human glioblastoma cell line, T98G, in which siRNA KD of ROCK1, AKT2, or PKA reduced total aggregate protein by 50–60% (Supplementary Figure S1c). The gene discussed is ROCK1; the disease is glioblastoma.